ISDB bulletins raise serious questions regarding the safety of using dronedarone (Multaq) for atrial fibrillation

ISDB bulletins raise serious questions regarding the safety of using dronedarone (Multaq) for atrial fibrillation

DTB-Navarre published an assessment report entitled “Dronedarone (Multaq®) for non-permanent atrial fibrillation. Lower efficacy than amiodarone and a questionable safety profile” (2011, No 5).

Excerpt (…) “Its safety profile is far from established. An increase in mortality in patients with heart failure and a warning of hepatic abnormalities have been published (…)

Read More

No Comments

Post A Comment